Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Clinical and Translational Oncology
Published in: Clinical and Translational Oncology 12/2010

01-12-2010 | Research Articles

Effect of delays on survival in patients with lung cancer

Authors: Francisco Javier González-Barcala, José María García-Prim, José Manuel Álvarez-Dobaño, Milagros Moldes-Rodríguez, María Teresa García-Sanz, Antonio Pose-Reino, Luis Valdés-Cuadrado

Published in: Clinical and Translational Oncology | Issue 12/2010

Login to get access
Metadata
Title
Effect of delays on survival in patients with lung cancer
Authors
Francisco Javier González-Barcala
José María García-Prim
José Manuel Álvarez-Dobaño
Milagros Moldes-Rodríguez
María Teresa García-Sanz
Antonio Pose-Reino
Luis Valdés-Cuadrado
Publication date
01-12-2010
Publisher
Springer Milan
Published in
Clinical and Translational Oncology / Issue 12/2010
Print ISSN: 1699-048X
Electronic ISSN: 1699-3055
DOI
https://doi.org/10.1007/s12094-010-0606-5

Other articles of this Issue 12/2010

Clinical and Translational Oncology 12/2010 Go to the issue

Research Articles

Efficacy of epoetin-beta 30,000 IU/week in correcting anaemia in patients with gastrointestinal tumours subjected to concomitant chemoradiotherapy

Research Articles

Computed tomography (CT) predicts accurately the pathologic tumour size in stage I non-small-cell lung cancer (NSCLC)

Education Alseries/Green Series

Treatment of high-risk neuroblastoma with anti-GD2 antibodies

News and Views/The Journalist Corner

Breast cancer: process of awareness

Editorial

The role of the radiation oncologist in oncology today

Educational Series/Red Series

Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal malignant disease
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits